Surface Phenotype of Freshly Isolated and CD1a-Enriched CML-Derived DCs
| Marker . | Freshly Isolated CML Cells . | DCs . |
|---|---|---|
| CD 1a | − | ++ |
| CD 3 | +/− | − |
| CD 4 | +/− | + |
| CD 8 | − | − |
| CD 13 | ++ | ++ |
| CD14 | − | − |
| CD 19 | − | − |
| CD 20 | − | − |
| CD 33 | ++ | ++ |
| CD 34 | − | − |
| CD 74* | + | − |
| CD 80 (B7-1) | − | + |
| CD 86 (B7-2) | − | ++ |
| HLA-ABC | ++ | ++ |
| HLA-DR | ++ | ++ |
| Marker . | Freshly Isolated CML Cells . | DCs . |
|---|---|---|
| CD 1a | − | ++ |
| CD 3 | +/− | − |
| CD 4 | +/− | + |
| CD 8 | − | − |
| CD 13 | ++ | ++ |
| CD14 | − | − |
| CD 19 | − | − |
| CD 20 | − | − |
| CD 33 | ++ | ++ |
| CD 34 | − | − |
| CD 74* | + | − |
| CD 80 (B7-1) | − | + |
| CD 86 (B7-2) | − | ++ |
| HLA-ABC | ++ | ++ |
| HLA-DR | ++ | ++ |
Abbreviations: −, 0% to 5%; +/−, 6% to 10%; +, 11% to 50%; ++, 51% to 100%.
Surface invariant chain.